Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM7E61Z)

Drug Name

GSK4381562 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Aggressive cancer	2A00-2F9Z	Phase 1	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Transmembrane protein PVRIG (PVRIG)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
COM701	DMXQOHV	Solid tumour/cancer	2A00-2F9Z	Phase 1	[3]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Transmembrane protein PVRIG (PVRIG)	TTOGCNT	PVRIG_HUMAN	Not Available	[2]

------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT05277051) A Phase 1 First-Time-in-Human, Open-Label Study of GSK4381562 Administered as Monotherapy and in Combination With Anticancer Agents in Participants With Selected Advanced Solid Tumors. U.S.National Institutes of Health.
2	Clinical pipeline report, company report or official report of GlaxoSmithKline
3	Clinical pipeline report, company report or official report of Compugen.